Medicare expenditures attributable to dementia.


Journal

Health services research
ISSN: 1475-6773
Titre abrégé: Health Serv Res
Pays: United States
ID NLM: 0053006

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 15 3 2019
medline: 30 1 2020
entrez: 15 3 2019
Statut: ppublish

Résumé

To estimate dementia's incremental cost to the traditional Medicare program. Health and Retirement Study (HRS) survey-linked Medicare part A and B claims from 1991 to 2012. We compared Medicare expenditures for 60 months following a claims-based dementia diagnosis to those for a randomly selected, matched comparison group. We used a cost estimator that accounts for differential survival between individuals with and without dementia and decomposes incremental costs into survival and cost intensity components. Dementia's five-year incremental cost to the traditional Medicare program is approximately $15 700 per patient, nearly half of which is incurred in the first year after diagnosis. Shorter survival with dementia mitigates the incremental cost by about $2650. Increased costs for individuals with dementia were driven by more intensive use of Medicare part A covered services. The incremental cost of dementia was about $7850 higher for females than for males because of sex-specific differential mortality associated with dementia. Dementia's cost to the traditional Medicare program is significant. Interventions that target early identification of dementia and preventable inpatient and post-acute care services could produce substantial savings.

Identifiants

pubmed: 30868557
doi: 10.1111/1475-6773.13134
pmc: PMC6606539
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

773-781

Subventions

Organisme : NIA NIH HHS
ID : R01 AG049815
Pays : United States
Organisme : NIA NIH HHS
ID : R01-AG049815
Pays : United States
Organisme : CDC HHS
ID : SIP-14-005
Pays : United States

Informations de copyright

© Health Research and Educational Trust.

Références

Ann Intern Med. 2015 Nov 17;163(10):729-36
pubmed: 26502320
Alzheimers Dement. 2016 Apr;12(4):459-509
pubmed: 27570871
J Am Geriatr Soc. 1998 Jun;46(6):762-70
pubmed: 9625195
J Alzheimers Dis. 2009;17(4):807-15
pubmed: 19542620
Health Serv Res. 2018 Feb;53(1):175-196
pubmed: 27873305
J Gerontol B Psychol Sci Soc Sci. 2013 Jul;68(4):562-7
pubmed: 23009955
Appl Health Econ Health Policy. 2013 Aug;11(4):407-13
pubmed: 23700254
J Am Geriatr Soc. 2004 Feb;52(2):187-94
pubmed: 14728626
J Am Geriatr Soc. 1994 May;42(5):517-21
pubmed: 8176147
Health Serv Res. 2019 Aug;54(4):773-781
pubmed: 30868557
Arch Intern Med. 2011 May 9;171(9):824-30
pubmed: 21220646
N Engl J Med. 2013 Dec 12;369(24):2275-7
pubmed: 24283198
Health Econ. 2010 Sep;19(9):1010-28
pubmed: 20665908
Inquiry. 2007-2008 Winter;44(4):481-94
pubmed: 18338520
JAMA Intern Med. 2017 Jan 1;177(1):51-58
pubmed: 27893041
Health Serv Res. 2012 Aug;47(4):1660-78
pubmed: 22171532
Health Aff (Millwood). 2014 Apr;33(4):667-74
pubmed: 24711329
Alzheimers Dement. 2013 Jan;9(1):63-75.e2
pubmed: 23305823
N Engl J Med. 2013 Apr 4;368(14):1326-34
pubmed: 23550670
Alzheimer Dis Assoc Disord. 2001 Oct-Dec;15(4):169-73
pubmed: 11723367
Health Serv Res. 2008 Apr;43(2):714-32
pubmed: 18370975
J Am Geriatr Soc. 2000 Jun;48(6):639-46
pubmed: 10855599
Womens Health Issues. 2015 Sep-Oct;25(5):436-40
pubmed: 26363924
Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):384-92
pubmed: 23687180
Forum Health Econ Policy. 2014 Nov;18(1):25-39
pubmed: 27134606
J Gen Intern Med. 1995 Apr;10(4):187-93
pubmed: 7790979
JAMA. 2012 Jan 11;307(2):165-72
pubmed: 22235087
J Gerontol A Biol Sci Med Sci. 2015 Nov;70(11):1448-53
pubmed: 26311543
J Am Geriatr Soc. 2016 Aug;64(8):1549-57
pubmed: 27295430

Auteurs

Lindsay White (L)

Department of Health Services, School of Public Health, University of Washington, Seattle, Washington.

Paul Fishman (P)

Department of Health Services, School of Public Health, University of Washington, Seattle, Washington.

Anirban Basu (A)

Department of Health Services, School of Public Health, University of Washington, Seattle, Washington.
Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington.
National Bureau of Economic Research, Cambridge, Massachusetts.

Paul K Crane (PK)

Division of General Internal Medicine, School of Medicine, University of Washington, Seattle, Washington.

Eric B Larson (EB)

Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, Washington.

Norma B Coe (NB)

National Bureau of Economic Research, Cambridge, Massachusetts.
Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH